Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Dr. Peter Attia

👤 Speaker
11186 total appearances

Appearances Over Time

Podcast Appearances

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

To believe that ivermectin cures cancer and to listen to the stories of multiple people with all sorts of different metastatic cancers that are cured, you're almost explaining that cancer is a single disease. So explain why, at face value, the idea that anything could cure multiple forms of cancer is an impossibility.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

To believe that ivermectin cures cancer and to listen to the stories of multiple people with all sorts of different metastatic cancers that are cured, you're almost explaining that cancer is a single disease. So explain why, at face value, the idea that anything could cure multiple forms of cancer is an impossibility.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

And when you go even one step further, as you've alluded to, it's not just that colon cancer and breast cancer are as different as kidney disease and heart disease.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

And when you go even one step further, as you've alluded to, it's not just that colon cancer and breast cancer are as different as kidney disease and heart disease.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

It's that breast cancer with an estrogen receptor that lights up versus a HER2 new receptor that lights up versus no receptors that lights up, those pretty much have nothing in common other than the fact that they originated from the mammary cell of a woman's breast.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

It's that breast cancer with an estrogen receptor that lights up versus a HER2 new receptor that lights up versus no receptors that lights up, those pretty much have nothing in common other than the fact that they originated from the mammary cell of a woman's breast.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

The other issue I have with this type of rhetoric is the next line that follows is the pharma companies all know this works. And the reason they're keeping it from you is so that they can make more money giving ineffective drugs. Now, again, I'm going to offer my point of view on this, but you being the veteran of some of the biggest pharma companies in the world, feel free to correct me.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

The other issue I have with this type of rhetoric is the next line that follows is the pharma companies all know this works. And the reason they're keeping it from you is so that they can make more money giving ineffective drugs. Now, again, I'm going to offer my point of view on this, but you being the veteran of some of the biggest pharma companies in the world, feel free to correct me.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

I think pharma would be happy to have a drug like ivermectin that cured all cancer because the first thing they would do is put a slightly different modification to it to make it more efficacious, basically less side effects, and they would patent it and they would make all the money in the world.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

I think pharma would be happy to have a drug like ivermectin that cured all cancer because the first thing they would do is put a slightly different modification to it to make it more efficacious, basically less side effects, and they would patent it and they would make all the money in the world.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

If they're able to make $100,000 on a drug that extends your life by eight months, I promise you they will be making millions per drug if it's curative. So again, such illogical arguments are put forth and it drives me sort of bananas. But if we want to go back and say, how did we get here? I think... When my friend Joe Rogan took ivermectin for COVID, which when Joe asked me, what do I think?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

If they're able to make $100,000 on a drug that extends your life by eight months, I promise you they will be making millions per drug if it's curative. So again, such illogical arguments are put forth and it drives me sort of bananas. But if we want to go back and say, how did we get here? I think... When my friend Joe Rogan took ivermectin for COVID, which when Joe asked me, what do I think?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

I said, Joe, I think it's a totally safe drug. I'm pretty sure it has nothing to do with why you're feeling better today. I think you're feeling better today because you have an amazing immune system. You're an insanely healthy human being. You did 10 other things, two of which might have worked. I'm pretty sure the ivermectin had nothing to do with it.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

I said, Joe, I think it's a totally safe drug. I'm pretty sure it has nothing to do with why you're feeling better today. I think you're feeling better today because you have an amazing immune system. You're an insanely healthy human being. You did 10 other things, two of which might have worked. I'm pretty sure the ivermectin had nothing to do with it.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

That said, the medical community didn't say that to him. What they said is you're taking horse dewormer, you idiot. Well, that was a strategic error. That's an awful way to talk to somebody. And ivermectin might be a horse dewormer. It also happens to be, and I look this up, Sue, there is no drug on planet earth that has been taken by more human beings than ivermectin.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

That said, the medical community didn't say that to him. What they said is you're taking horse dewormer, you idiot. Well, that was a strategic error. That's an awful way to talk to somebody. And ivermectin might be a horse dewormer. It also happens to be, and I look this up, Sue, there is no drug on planet earth that has been taken by more human beings than ivermectin.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

And it might have the fewest side effects of any drug out there.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

And it might have the fewest side effects of any drug out there.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Works beyond, yeah, exactly.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Works beyond, yeah, exactly.